Marshall Wace North America’s Trueblue TBI Stock Holding History

Marshall Wace North America’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,330	Closed	-$28K	–	1591
2019 Q3	$28K	Buy	+1,330	New	+$27.5K	﹤0.01%	1214

Other funds holding TBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Marshall Wace North America's TBI Position: Q4 2019 in Review

Marshall Wace North America sold out of Trueblue (TBI) in Q4 2019, closing a stake of 1,330 shares — an estimated $28K sold.

Marshall Wace North America first reported a position in TBI in Q3 2019 and held it in 1 quarter. The position peaked at $28K in Q3 2019. 172 funds tracked by Wall St. Rank hold TBI as of Q4 2019.

Marshall Wace North America reported no remaining Trueblue position as of Q4 2019 after selling out during the quarter.
Marshall Wace North America sold 1,330 Trueblue shares in Q4 2019, an estimated $28K.
Marshall Wace North America first reported a position in Trueblue in Q3 2019 and held it in 1 quarter.
Marshall Wace North America's Trueblue position peaked at $28K in Q3 2019.
172 funds tracked by Wall St. Rank held Trueblue as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.